HEADER PEPTIDE BINDING PROTEIN 23-APR-24 9BIE TITLE HUMAN ZYG11B ELONGINB/C COMPLEX BINDING TO SARS-COV2 ORF10 PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN ZYG-11 HOMOLOG B; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ELONGIN-B; COMPND 7 CHAIN: B; COMPND 8 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 9 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 10 POLYPEPTIDE 2; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: ELONGIN-C; COMPND 14 CHAIN: C; COMPND 15 SYNONYM: ELOC, ELONGIN 15 KDA SUBUNIT, RNA POLYMERASE II COMPND 16 TRANSCRIPTION FACTOR SIII SUBUNIT C, SIII P15, TRANSCRIPTION COMPND 17 ELONGATION FACTOR B POLYPEPTIDE 1; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 4; COMPND 20 MOLECULE: PUTATIVE ORF10 PROTEIN; COMPND 21 CHAIN: P; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ZYG11B, KIAA1730; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ELOB, TCEB2; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: ELOC, TCEB1; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 22 MOL_ID: 4; SOURCE 23 SYNTHETIC: YES; SOURCE 24 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 25 2; SOURCE 26 ORGANISM_COMMON: SARS-COV-2, 2019-NCOV, COVID-19 VIRUS; SOURCE 27 ORGANISM_TAXID: 2697049 KEYWDS GLY/N DEGRON, PEPTIDE BINDING PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR X.LIU,J.D.GROSS REVDAT 1 18-MAR-26 9BIE 0 JRNL AUTH X.LIU,J.D.GROSS JRNL TITL HUMAN ZYG11B/ELONGIN-B/C BINDING TO SARS-COV2 ORF10 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.LIEBSCHNER,P.V.AFONINE,M.L.BAKER,G.BUNKOCZI,V.B.CHEN, REMARK 1 AUTH 2 T.I.CROLL,B.HINTZE,L.W.HUNG,S.JAIN,A.J.MCCOY,N.W.MORIARTY, REMARK 1 AUTH 3 R.D.OEFFNER,B.K.POON,M.G.PRISANT,R.J.READ,J.S.RICHARDSON, REMARK 1 AUTH 4 D.C.RICHARDSON,M.D.SAMMITO,O.V.SOBOLEV,D.H.STOCKWELL, REMARK 1 AUTH 5 T.C.TERWILLIGER,A.G.URZHUMTSEV,L.L.VIDEAU,C.J.WILLIAMS, REMARK 1 AUTH 6 P.D.ADAMS REMARK 1 TITL MACROMOLECULAR STRUCTURE DETERMINATION USING X-RAYS, REMARK 1 TITL 2 NEUTRONS AND ELECTRONS: RECENT DEVELOPMENTS IN PHENIX REMARK 1 REF ACTA CRYSTALLOGR., SECT. D: V. 75 861 2019 REMARK 1 REF 2 BIOL. CRYSTALLOGR. REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 31588918 REMARK 1 DOI 10.1107/S2059798319011471 REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.400 REMARK 3 NUMBER OF PARTICLES : 325264 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9BIE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-24. REMARK 100 THE DEPOSITION ID IS D_1000283444. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : TERNARY COMPLEX OF ZYG11B AND REMARK 245 ELON/C REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.25 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 5000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : 4D-STEM REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -3 REMARK 465 HIS A -2 REMARK 465 MET A -1 REMARK 465 VAL A 0 REMARK 465 ASP A 1 REMARK 465 PRO A 2 REMARK 465 GLU A 3 REMARK 465 ASP A 4 REMARK 465 GLN A 5 REMARK 465 ALA A 6 REMARK 465 GLY A 7 REMARK 465 ALA A 8 REMARK 465 ALA A 9 REMARK 465 MET A 10 REMARK 465 GLU A 11 REMARK 465 GLU A 12 REMARK 465 PRO A 734 REMARK 465 CYS A 735 REMARK 465 LYS A 736 REMARK 465 LYS A 737 REMARK 465 GLN A 738 REMARK 465 PRO A 739 REMARK 465 GLN A 740 REMARK 465 ALA A 741 REMARK 465 ARG A 742 REMARK 465 LEU A 743 REMARK 465 ASN A 744 REMARK 465 LEU B 99 REMARK 465 PRO B 100 REMARK 465 ASP B 101 REMARK 465 VAL B 102 REMARK 465 MET B 103 REMARK 465 LYS B 104 REMARK 465 PRO B 105 REMARK 465 GLN B 106 REMARK 465 ASP B 107 REMARK 465 SER B 108 REMARK 465 GLY B 109 REMARK 465 SER B 110 REMARK 465 SER B 111 REMARK 465 ALA B 112 REMARK 465 ASN B 113 REMARK 465 GLU B 114 REMARK 465 GLN B 115 REMARK 465 ALA B 116 REMARK 465 VAL B 117 REMARK 465 GLN B 118 REMARK 465 MET P 1 REMARK 465 LEU P 17 REMARK 465 LEU P 18 REMARK 465 CYS P 19 REMARK 465 ARG P 20 REMARK 465 MET P 21 REMARK 465 ASN P 22 REMARK 465 SER P 23 REMARK 465 ARG P 24 REMARK 465 ASN P 25 REMARK 465 TYR P 26 REMARK 465 ILE P 27 REMARK 465 ALA P 28 REMARK 465 GLN P 29 REMARK 465 VAL P 30 REMARK 465 ASP P 31 REMARK 465 VAL P 32 REMARK 465 VAL P 33 REMARK 465 ASN P 34 REMARK 465 PHE P 35 REMARK 465 ASN P 36 REMARK 465 LEU P 37 REMARK 465 THR P 38 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LYS C 80 OG1 THR C 84 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 590 CA - CB - CG ANGL. DEV. = 14.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 116 -159.26 -147.60 REMARK 500 ALA A 117 63.27 65.42 REMARK 500 ASP A 118 -7.28 74.86 REMARK 500 GLU A 235 53.88 -91.05 REMARK 500 LYS A 248 -2.77 70.28 REMARK 500 ASP A 253 32.86 -96.90 REMARK 500 LEU A 265 63.74 61.93 REMARK 500 LEU A 299 28.28 -140.89 REMARK 500 ASP A 303 49.06 32.56 REMARK 500 GLN A 393 -131.59 54.16 REMARK 500 ASN A 508 62.90 60.14 REMARK 500 CYS A 643 -135.22 55.00 REMARK 500 PHE B 15 58.74 -95.96 REMARK 500 GLU B 41 57.20 -96.15 REMARK 500 ASP B 47 56.80 32.09 REMARK 500 ASP B 48 61.61 62.65 REMARK 500 ASP B 83 -2.23 65.81 REMARK 500 GLU C 56 -7.15 72.10 REMARK 500 ASN P 5 -136.82 67.71 REMARK 500 PHE P 7 -2.09 75.08 REMARK 500 PHE P 9 54.30 39.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-44589 RELATED DB: EMDB REMARK 900 HUMAN ZYG11B ELONGINB/C COMPLEX BINDING TO SARS-COV2 ORF10 PROTEIN DBREF 9BIE A 2 744 UNP Q9C0D3 ZY11B_HUMAN 2 744 DBREF 9BIE B 1 118 UNP Q15370 ELOB_HUMAN 1 118 DBREF 9BIE C 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF1 9BIE P 1 38 UNP ORF10_SARS2 DBREF2 9BIE P A0A663DJA2 1 38 SEQADV 9BIE SER A -3 UNP Q9C0D3 EXPRESSION TAG SEQADV 9BIE HIS A -2 UNP Q9C0D3 EXPRESSION TAG SEQADV 9BIE MET A -1 UNP Q9C0D3 EXPRESSION TAG SEQADV 9BIE VAL A 0 UNP Q9C0D3 EXPRESSION TAG SEQADV 9BIE ASP A 1 UNP Q9C0D3 EXPRESSION TAG SEQRES 1 A 748 SER HIS MET VAL ASP PRO GLU ASP GLN ALA GLY ALA ALA SEQRES 2 A 748 MET GLU GLU ALA SER PRO TYR SER LEU LEU ASP ILE CYS SEQRES 3 A 748 LEU ASN PHE LEU THR THR HIS LEU GLU LYS PHE CYS SER SEQRES 4 A 748 ALA ARG GLN ASP GLY THR LEU CYS LEU GLN GLU PRO GLY SEQRES 5 A 748 VAL PHE PRO GLN GLU VAL ALA ASP ARG LEU LEU ARG THR SEQRES 6 A 748 MET ALA PHE HIS GLY LEU LEU ASN ASP GLY THR VAL GLY SEQRES 7 A 748 ILE PHE ARG GLY ASN GLN MET ARG LEU LYS ARG ALA CYS SEQRES 8 A 748 ILE ARG LYS ALA LYS ILE SER ALA VAL ALA PHE ARG LYS SEQRES 9 A 748 ALA PHE CYS HIS HIS LYS LEU VAL GLU LEU ASP ALA THR SEQRES 10 A 748 GLY VAL ASN ALA ASP ILE THR ILE THR ASP ILE ILE SER SEQRES 11 A 748 GLY LEU GLY SER ASN LYS TRP ILE GLN GLN ASN LEU GLN SEQRES 12 A 748 CYS LEU VAL LEU ASN SER LEU THR LEU SER LEU GLU ASP SEQRES 13 A 748 PRO TYR GLU ARG CYS PHE SER ARG LEU SER GLY LEU ARG SEQRES 14 A 748 ALA LEU SER ILE THR ASN VAL LEU PHE TYR ASN GLU ASP SEQRES 15 A 748 LEU ALA GLU VAL ALA SER LEU PRO ARG LEU GLU SER LEU SEQRES 16 A 748 ASP ILE SER ASN THR SER ILE THR ASP ILE THR ALA LEU SEQRES 17 A 748 LEU ALA CYS LYS ASP ARG LEU LYS SER LEU THR MET HIS SEQRES 18 A 748 HIS LEU LYS CYS LEU LYS MET THR THR THR GLN ILE LEU SEQRES 19 A 748 ASP VAL VAL ARG GLU LEU LYS HIS LEU ASN HIS LEU ASP SEQRES 20 A 748 ILE SER ASP ASP LYS GLN PHE THR SER ASP ILE ALA LEU SEQRES 21 A 748 ARG LEU LEU GLU GLN LYS ASP ILE LEU PRO ASN LEU VAL SEQRES 22 A 748 SER LEU ASP VAL SER GLY ARG LYS HIS VAL THR ASP LYS SEQRES 23 A 748 ALA VAL GLU ALA PHE ILE GLN GLN ARG PRO SER MET GLN SEQRES 24 A 748 PHE VAL GLY LEU LEU ALA THR ASP ALA GLY TYR SER GLU SEQRES 25 A 748 PHE LEU THR GLY GLU GLY HIS LEU LYS VAL SER GLY GLU SEQRES 26 A 748 ALA ASN GLU THR GLN ILE ALA GLU ALA LEU LYS ARG TYR SEQRES 27 A 748 SER GLU ARG ALA PHE PHE VAL ARG GLU ALA LEU PHE HIS SEQRES 28 A 748 LEU PHE SER LEU THR HIS VAL MET GLU LYS THR LYS PRO SEQRES 29 A 748 GLU ILE LEU LYS LEU VAL VAL THR GLY MET ARG ASN HIS SEQRES 30 A 748 PRO MET ASN LEU PRO VAL GLN LEU ALA ALA SER ALA CYS SEQRES 31 A 748 VAL PHE ASN LEU THR LYS GLN ASP LEU ALA ALA GLY MET SEQRES 32 A 748 PRO VAL ARG LEU LEU ALA ASP VAL THR HIS LEU LEU LEU SEQRES 33 A 748 LYS ALA MET GLU HIS PHE PRO ASN HIS GLN GLN LEU GLN SEQRES 34 A 748 LYS ASN CYS LEU LEU SER LEU CYS SER ASP ARG ILE LEU SEQRES 35 A 748 GLN ASP VAL PRO PHE ASN ARG PHE GLU ALA ALA LYS LEU SEQRES 36 A 748 VAL MET GLN TRP LEU CYS ASN HIS GLU ASP GLN ASN MET SEQRES 37 A 748 GLN ARG MET ALA VAL ALA ILE ILE SER ILE LEU ALA ALA SEQRES 38 A 748 LYS LEU SER THR GLU GLN THR ALA GLN LEU GLY THR GLU SEQRES 39 A 748 LEU PHE ILE VAL ARG GLN LEU LEU GLN ILE VAL LYS GLN SEQRES 40 A 748 LYS THR ASN GLN ASN SER VAL ASP THR THR LEU LYS PHE SEQRES 41 A 748 THR LEU SER ALA LEU TRP ASN LEU THR ASP GLU SER PRO SEQRES 42 A 748 THR THR CYS ARG HIS PHE ILE GLU ASN GLN GLY LEU GLU SEQRES 43 A 748 LEU PHE MET ARG VAL LEU GLU SER PHE PRO THR GLU SER SEQRES 44 A 748 SER ILE GLN GLN LYS VAL LEU GLY LEU LEU ASN ASN ILE SEQRES 45 A 748 ALA GLU VAL GLN GLU LEU HIS SER GLU LEU MET TRP LYS SEQRES 46 A 748 ASP PHE ILE ASP HIS ILE SER SER LEU LEU HIS SER VAL SEQRES 47 A 748 GLU VAL GLU VAL SER TYR PHE ALA ALA GLY ILE ILE ALA SEQRES 48 A 748 HIS LEU ILE SER ARG GLY GLU GLN ALA TRP THR LEU SER SEQRES 49 A 748 ARG SER GLN ARG ASN SER LEU LEU ASP ASP LEU HIS SER SEQRES 50 A 748 ALA ILE LEU LYS TRP PRO THR PRO GLU CYS GLU MET VAL SEQRES 51 A 748 ALA TYR ARG SER PHE ASN PRO PHE PHE PRO LEU LEU GLY SEQRES 52 A 748 CYS PHE THR THR PRO GLY VAL GLN LEU TRP ALA VAL TRP SEQRES 53 A 748 ALA MET GLN HIS VAL CYS SER LYS ASN PRO SER ARG TYR SEQRES 54 A 748 CYS SER MET LEU ILE GLU GLU GLY GLY LEU GLN HIS LEU SEQRES 55 A 748 TYR ASN ILE LYS ASP HIS GLU HIS THR ASP PRO HIS VAL SEQRES 56 A 748 GLN GLN ILE ALA VAL ALA ILE LEU ASP SER LEU GLU LYS SEQRES 57 A 748 HIS ILE VAL ARG HIS GLY ARG PRO PRO PRO CYS LYS LYS SEQRES 58 A 748 GLN PRO GLN ALA ARG LEU ASN SEQRES 1 B 118 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 B 118 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 B 118 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 B 118 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 B 118 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 B 118 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 B 118 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CYS ILE GLU SEQRES 8 B 118 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 9 B 118 PRO GLN ASP SER GLY SER SER ALA ASN GLU GLN ALA VAL SEQRES 10 B 118 GLN SEQRES 1 C 96 MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU PHE SEQRES 2 C 96 ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR ILE SEQRES 3 C 96 LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU ASN SEQRES 4 C 96 GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER HIS SEQRES 5 C 96 VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS VAL SEQRES 6 C 96 ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE PRO SEQRES 7 C 96 ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA ALA SEQRES 8 C 96 ASN PHE LEU ASP CYS SEQRES 1 P 38 MET GLY TYR ILE ASN VAL PHE ALA PHE PRO PHE THR ILE SEQRES 2 P 38 TYR SER LEU LEU LEU CYS ARG MET ASN SER ARG ASN TYR SEQRES 3 P 38 ILE ALA GLN VAL ASP VAL VAL ASN PHE ASN LEU THR HELIX 1 AA1 SER A 17 HIS A 29 1 13 HELIX 2 AA2 HIS A 29 PHE A 33 1 5 HELIX 3 AA3 PRO A 51 HIS A 65 1 15 HELIX 4 AA4 ASN A 69 GLY A 74 1 6 HELIX 5 AA5 ILE A 75 ARG A 77 5 3 HELIX 6 AA6 SER A 94 PHE A 102 1 9 HELIX 7 AA7 THR A 120 SER A 130 1 11 HELIX 8 AA8 ASN A 131 LEU A 138 1 8 HELIX 9 AA9 TYR A 175 ALA A 183 1 9 HELIX 10 AB1 ILE A 201 LYS A 208 5 8 HELIX 11 AB2 THR A 225 GLU A 235 1 11 HELIX 12 AB3 ASP A 253 GLN A 261 1 9 HELIX 13 AB4 THR A 280 ARG A 291 1 12 HELIX 14 AB5 ASN A 323 TYR A 334 1 12 HELIX 15 AB6 ARG A 337 HIS A 353 1 17 HELIX 16 AB7 LYS A 359 HIS A 373 1 15 HELIX 17 AB8 ASN A 376 THR A 391 1 16 HELIX 18 AB9 GLN A 393 GLY A 398 1 6 HELIX 19 AC1 PRO A 400 PHE A 418 1 19 HELIX 20 AC2 HIS A 421 CYS A 433 1 13 HELIX 21 AC3 SER A 434 ASP A 440 1 7 HELIX 22 AC4 ASN A 444 CYS A 457 1 14 HELIX 23 AC5 ASP A 461 ALA A 477 1 17 HELIX 24 AC6 SER A 480 GLU A 490 1 11 HELIX 25 AC7 LEU A 491 ASN A 508 1 18 HELIX 26 AC8 ASP A 511 THR A 525 1 15 HELIX 27 AC9 SER A 528 ASN A 538 1 11 HELIX 28 AD1 GLY A 540 PHE A 551 1 12 HELIX 29 AD2 GLU A 554 ALA A 569 1 16 HELIX 30 AD3 LEU A 574 LEU A 578 5 5 HELIX 31 AD4 TRP A 580 HIS A 592 1 13 HELIX 32 AD5 GLU A 595 SER A 611 1 17 HELIX 33 AD6 SER A 620 LEU A 636 1 17 HELIX 34 AD7 PHE A 651 PHE A 655 5 5 HELIX 35 AD8 THR A 663 ASN A 681 1 19 HELIX 36 AD9 ASN A 681 GLY A 693 1 13 HELIX 37 AE1 GLY A 694 ASP A 703 1 10 HELIX 38 AE2 ASP A 708 GLY A 730 1 23 HELIX 39 AE3 THR B 23 LYS B 36 1 14 HELIX 40 AE4 LYS C 32 LEU C 37 1 6 HELIX 41 AE5 SER C 39 SER C 47 1 9 HELIX 42 AE6 PRO C 49 ALA C 53 5 5 HELIX 43 AE7 PRO C 66 THR C 84 1 19 HELIX 44 AE8 ILE C 99 LEU C 110 1 12 HELIX 45 AE9 PHE P 11 LEU P 16 1 6 SHEET 1 AA1 2 CYS A 34 ALA A 36 0 SHEET 2 AA1 2 LEU A 42 LEU A 44 -1 O CYS A 43 N SER A 35 SHEET 1 AA2 4 ARG A 85 CYS A 87 0 SHEET 2 AA2 4 GLU A 109 ASP A 111 1 O GLU A 109 N ALA A 86 SHEET 3 AA2 4 CYS A 140 VAL A 142 1 O VAL A 142 N LEU A 110 SHEET 4 AA2 4 ALA A 166 SER A 168 1 O ALA A 166 N LEU A 141 SHEET 1 AA3 3 SER A 270 ASP A 272 0 SHEET 2 AA3 3 PHE A 296 GLY A 298 1 O PHE A 296 N LEU A 271 SHEET 3 AA3 3 LYS A 317 SER A 319 1 O SER A 319 N VAL A 297 SHEET 1 AA4 4 ASP B 17 LYS B 19 0 SHEET 2 AA4 4 ASP B 2 ILE B 7 -1 N VAL B 3 O ALA B 18 SHEET 3 AA4 4 ALA B 73 LEU B 77 1 O VAL B 75 N MET B 6 SHEET 4 AA4 4 LEU B 44 TYR B 45 -1 N TYR B 45 O GLY B 76 SHEET 1 AA5 4 THR B 12 ILE B 14 0 SHEET 2 AA5 4 GLU C 28 VAL C 31 1 O ILE C 30 N THR B 13 SHEET 3 AA5 4 VAL C 19 ILE C 22 -1 N VAL C 19 O VAL C 31 SHEET 4 AA5 4 VAL C 60 ASN C 61 1 O VAL C 60 N LYS C 20 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 258 0 0 45 17 0 0 6 7374 4 0 79 END